Attending Companies
Companies who have attended EPIC recently include:
| Company |
|---|
| AAI Deutschland |
| Abingworth |
| Ablynx |
| ACE BioSciences |
| ActoGeniX |
| Adaptimmune |
| Adamant Ventures |
| Addex |
| Addos Consulting |
| Advancell |
| Affectis |
| Affitech AS |
| Agenda 1 Analytical Services |
| Alacrita Consulting |
| ALFAMA |
| Alligator Bioscience |
| Alltech UK |
| Almac Group |
| Alpha Biologics |
| AM Pharma |
| Amgen |
| ANIMASCOPE |
| Apitope |
| Aquapharm |
| Archimedes Pharma |
| ArisGen |
| Asterion |
| AstraZeneca |
| Atlas Genetics |
| Atlas Venture |
| AUSTRIANOVA |
| Axordia Ltd |
| Azur Pharma |
| Basinc |
| Bergen Bio |
| Bio2Business |
| Bioanalytical Systems Ltd |
| Bioceramic Therapeutics |
| Biocortech |
| Biocompatibles International |
| BioDynamics Research Ltd |
| BioFocus DPI Ltd |
| Biogenetica Inc |
| Bio-Medisinsk Innovasjon AS |
| BioPartnering Magazine |
| Biosensia |
| Biotecnol |
| Biotecnol SA |
| BioThema |
| Biotie Therapies |
| BioUETIKON Ltd |
| BioValue |
| Bird & Bird |
| Birkeland Innovation AS |
| Bodycote Health Sciences |
| Boult Wade Tennant |
| Bridgehead International |
| Bristol Myers Squibb |
| BT PHARMA |
| BTG plc |
| Buchanan Communications Ltd |
| CA Baxter Consulting |
| Cambridge Consultants Ltd |
| Cambridge Enterprise Ltd |
| Cambridge Healthcare & Biotech |
| Cambridge Major Laboratories |
| CancerCure |
| Capital MS & L |
| CCLRC Daresbury Laboratory |
| Celentyx |
| Cell Medica |
| CeNes Pharmaceuticals |
| Centre For Process Innovation |
| Cephalon |
| Charles River |
| Citigate Dewe Rogerson |
| Clarkslegal |
| Clavicle Partners |
| Clinica World Medical Technology |
| CMC Biologics |
| CMC Biopharmaceuticals |
| CMS Cameron Mckenna |
| Cognitive Drug Research |
| College Hill |
| Conformetrix |
| Covagen |
| Covington & Burling |
| Crescent Diagnostics |
| Cresset BioMolecular Discovery |
| CureVac |
| Curidium |
| Cyclacel |
| Cyprotex Discovery |
| Dalriada Resources |
| Debiopharm |
| Dechert LLP |
| deCODE chemistry & deCODE biostructures |
| Department of Industry |
| Direvo Biotech |
| Diurnal |
| DNage |
| Domainex |
| Domain Therapeutics |
| Dompe |
| Dorsey & Whitney LLP |
| Dundas & Wilson CS |
| Easton Associates |
| ECI Partners |
| Eisai |
| EGeen International Corp |
| Elexopharm |
| Eli Lilly & Company Ltd |
| Ellipse Pharmaceuticals |
| Epistem |
| ERA Consulting |
| ERBi |
| ERYtech Pharma |
| Esperante |
| Ethical Oncology Science |
| European Equity Partners |
| Evotec |
| Eye Tube |
| Eykpna |
| Falco Therapeutics |
| Farallone Therapeutics |
| Ferghana Partners |
| Fernleigh |
| Ferring Research Ltd |
| Finance Wales |
| Fischer Scientific |
| Forresters |
| Fry Spence & Heath LLP |
| Fusion Antibodies |
| Galapagos |
| Galen |
| Gel Delivery Solutions |
| Genex BioSystems |
| Genextra |
| Gilde Healthcare Partners |
| Glide Pharma |
| Glycoform |
| g-Nostics |
| g-Nostics |
| GlaxoSmithKlein |
| Goffin Consultancy |
| Gregory Fryer Assiciates |
| Haemostatix |
| Halo BioConsulting |
| Hayhurst Media |
| Health Protection Agency |
| Henogen |
| Heptares |
| Hesperion Ltd |
| High Commission of Canada |
| High Force Research |
| HLBBshaw |
| Huntingdon Life Sciences |
| Hybrid Systems |
| Hypoxium |
| ICON Developement Solutions |
| IDDI |
| Immatics |
| Immune Targeting Systems |
| Imperial College |
| Incentec |
| Independent Consultant |
| Insert Therapeutics Inc |
| Institute of Cancer Research |
| Institute of Pharmaceutical Innovation |
| Intercytex |
| Interea International |
| Intertek |
| IP Pragmatics |
| Ipsat Therapies |
| IPSO Ventures |
| ISG Plc |
| Isis Innovation |
| Isogenica |
| ITI Life Sciences |
| JA Kemp & Co |
| James Cowper |
| Jerini |
| Karus Therapeutics |
| KCL Business |
| Kiadis Pharma |
| KWS BioTest |
| Lamellar Biomedical Ltd |
| Lectus Therapeutics |
| Lein Applied Diagnostics |
| LEO Pharma |
| Life Scientific Ltd |
| LifeCycle Pharma |
| Lipoxen |
| London BioAlliance |
| London Bioscience Innovation Centre |
| London Biotechnology Network |
| London Genetics |
| London Regenerative Medicine Network |
| London Technology Fund |
| Lonza Biologics |
| LSA |
| Ludger |
| Med Discovery |
| Medella Therapeutics |
| Media Speak |
| Medical Solutions |
| Mediscis |
| Mednous |
| Medpharm |
| Medpharm |
| Mercia Fund |
| Mercia Technology Seed Fund |
| Merck Sharp & Dohme |
| Metabometrix |
| Microsens Biotechnologies |
| Millipore (UK) Ltd |
| Modern Biosciences plc |
| Model Gut |
| MP5 |
| MTI Partners |
| Multimmune GmbH |
| MVM Life Science Partners |
| Nature Publishing Group |
| NESTA |
| Neuro-Zone |
| Newport Pharmaceuticals |
| NHS Innovations London |
| Nippon Shinyaku |
| Noble Fund Managers |
| Novagali Pharma |
| Novamass |
| Novartis Pharma AG |
| Novartis UK |
| NovaSecta |
| Novasep Synthesis |
| Novolytics |
| NSGene |
| NVM Private Equity |
| OctoPlus BV |
| Omnicyte |
| Orla protien Technologies |
| Orthox |
| Oxford Capital Partners |
| Oxfordshire Bioscience Network |
| Oy Leiras Finland |
| Page White & Farrer |
| Paion |
| Panacea Clinical Research |
| Paramount Biosciences, LLC |
| Patheon UK Ltd |
| Paul Capital Advisors UK Ltd |
| Peakdale Molecular Ltd |
| People in Helath |
| PERA |
| Pfizer Ltd |
| PGIS |
| Pharmaceutical & Biotech consulting |
| PharmaCore |
| PharmaKodex Ltd |
| PharmaNet Development Group |
| Pharmatory Ltd |
| Pharmaxon |
| Pharmidex |
| Pharminox |
| Pharmovation |
| Phico Therapeutics |
| Phynova Group Plc |
| Physiomics |
| Phytopharm |
| PiR Group |
| Plasticell |
| Polytherics |
| PricewaterhouseCoopers LLP |
| Prn Clinical Services |
| Procarta Biosystems |
| ProCitius Research |
| Promega UK |
| Pronota |
| ProPharma Partners Ltd |
| Protein'eXpert |
| Protexa Therapeutics |
| Protherics |
| Proxima Concepts |
| Psi-napse |
| Psynova Neurotech |
| Queen Mary Innovation Ltd |
| Quester |
| Quintiles |
| Quotient Bioresearch |
| Quotient Diagnostics |
| R&D Focus |
| R5 Pharmaceuticals |
| Remtec Search & Selection |
| ReNeuron |
| Revolymer |
| Richter-Helm Biotech |
| RNTech |
| Roche |
| Rosetta Capital |
| RSA |
| Ruston Poole International |
| RWS Group |
| Sai Advantium Pharma |
| Santaris Pharma |
| Sareum |
| Scientific Update |
| SCM Pharma |
| Scottish Equity Partners |
| SCRIP |
| Selcia |
| Selexis |
| Senexis |
| Sentinal Oncology |
| Seroba Bioventures |
| Seventure Partners |
| Siegfried |
| Sigma-Aldrich Company Ltd |
| Sigmoid Pharma |
| Six Swiss Exchange AG |
| SJ Berwin |
| Soffinova |
| Solace Pharma |
| Specials Clinical Manufacturing |
| Spinal Bliss |
| Stabilitech |
| STI Pharmaceuticals Ltd |
| Strathmann Biotec |
| Sudbrook Associates LLP |
| Surface Therapeutics |
| Synosia |
| Syntaxin |
| Taylor Wessing |
| Teva Pharmaceutical Industries |
| The Ann Hayes Consultancy Ltd |
| The Austin Company of UK |
| The Welcome Trust |
| Thomas Eggar LLP |
| TiGenix |
| Transcrip Partners |
| Trial Form Support |
| Trillium Medical Ventures |
| Trophos |
| UMIC |
| University of Nottingham |
| University of Southampton |
| Upperton Ltd |
| ValiRx |
| Venner Shipley LLP |
| VENTECH |
| VEREENIGDE Octrooibureaux NV |
| Vivamer |
| Warwick Effect Polymers |
| Withers & Rogers |
| Xceleron Ltd |
| Xenva |
| Xytis |
| Yamanouchi |
| York Pharma Plc |
| Ziva Biosciences |
